Brewin Dolphin Wealth Management LTD Abbott Laboratories Transaction History
Brewin Dolphin Wealth Management LTD
- $917 Million
- Q2 2022
A detailed history of Brewin Dolphin Wealth Management LTD transactions in Abbott Laboratories stock. As of the latest transaction made, Brewin Dolphin Wealth Management LTD holds 1,306 shares of ABT stock, worth $148,897. This represents 0.02% of its overall portfolio holdings.
Number of Shares
1,306
Previous 1,306
-0.0%
Holding current value
$148,897
Previous $155,000
8.39%
% of portfolio
0.02%
Previous 0.02%
Shares
8 transactions
Others Institutions Holding ABT
# of Institutions
3,136Shares Held
1.33BCall Options Held
8.63MPut Options Held
7.17M-
Vanguard Group Inc Valley Forge, PA166MShares$19 Billion0.34% of portfolio
-
Black Rock Inc. New York, NY131MShares$15 Billion0.31% of portfolio
-
State Street Corp Boston, MA74.4MShares$8.48 Billion0.34% of portfolio
-
Capital International Investors Los Angeles, CA71.8MShares$8.19 Billion1.57% of portfolio
-
Capital Research Global Investors Los Angeles, CA57.2MShares$6.53 Billion1.34% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $200B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...